Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03340766
Title Open Label Study Investigating the Safety and Efficacy of Blinatumomab in Combination With Pembrolizumab (KEYNOTE-348)
Acronym HARBOUR
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Research Site La Jolla California 92093-0960 United States Details
Research Site Charleston South Carolina 29424 United States Details
Research Site Greenville South Carolina 29607 United States Details
Research Site Darlinghurst New South Wales 2010 Australia Details
Research Site St Leonards New South Wales 2065 Australia Details
Research Site Adelaide South Australia 5000 Australia Details
Research Site East Melbourne Victoria 3002 Australia Details
Research Site Geelong Victoria 3220 Australia Details
Research Site Melbourne Victoria 3004 Australia Details
Research Site Murdoch Western Australia 6150 Australia Details
Research Site Créteil Cedex 94010 France Details
Research Site Nantes Cedex 1 44035 France Details
Research Site Pierre-Benite 69495 France Details
Research Site Heidelberg 69120 Germany Details
Research Site Ulm 89081 Germany Details
Research Site Würzburg 97080 Germany Details
Research Site Maastricht 6229 HX Netherlands Details
Research Site Rotterdam 3015 CN Netherlands Details
Research Site Santander Cantabria 39008 Spain Details
Research Site Salamanca Castilla León 37007 Spain Details
Research Site Barcelona Cataluña 08025 Spain Details
Research Site Madrid 28046 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field